Inflammatory pattern recognition receptors and their ligands: Factors contributing to the pathogenesis of preeclampsia

Inflammation Research

Volumn 60, Issue 6, 2011, Pages 509-520

  Sado, Toshiyuki ^a   Naruse, Katsuhiko ^a   Noguchi, Taketoshi ^a   Haruta, Shoji ^a   Yoshida, Shozo ^a   Tanase, Yasuhito ^a   Kitanaka, Takashi ^a   Oi, Hidekazu ^a   Kobayashi, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Inflammation; Oxidative stress; Preeclampsia; RAGE; TLR

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER; CD36 ANTIGEN; CYTOKINE; GALAPTIN; GALECTIN 3; HIGH MOBILITY GROUP B1 PROTEIN; MEMBRANE RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PATTERN RECOGNITION RECEPTOR; PREALBUMIN; PROTEIN S 100; PROTEINASE; SCAVENGER RECEPTOR A; SCAVENGER RECEPTOR BI; STABILIN 1; STABILIN 2; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; CARBOHYDRATE METABOLISM; CHRONIC INFLAMMATION; DETOXIFICATION; GENE EXPRESSION PROFILING; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; LIPID METABOLISM; MICROARRAY ANALYSIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PREECLAMPSIA; PROTEIN EXPRESSION; PROTEOMICS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; LIGANDS; PRE-ECLAMPSIA; PREGNANCY; PROTEOMICS; RECEPTORS, PATTERN RECOGNITION;

EID: 79956202688     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-011-0319-4     Document Type: Review

References (86)

1. JM Davison V Homuth A Jeyabalan KP Conrad SA Karumanchi S Quaggin R Dechend FC Luft 2004 New aspects in the pathophysiology of preeclampsia J Am Soc Nephrol 15 2440 2448 15339993 10.1097/01.ASN.0000135975.90889.60 1:CAS:528:DC%2BD2cXntVehtrg%3D (Pubitemid 39159344)
2. WP Mutter SA Karumanchi 2008 Molecular mechanisms of preeclampsia Microvasc Res 75 1 1 8 17553534 10.1016/j.mvr.2007.04.009 1:CAS:528: DC%2BD1cXhtV2rsw%3D%3D (Pubitemid 350266733)
3. CS Facemire AB Nixon R Griffiths H Hurwitz TM Coffman 2009 Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression Hypertension 54 652 658 19652084 10.1161/HYPERTENSIONAHA.109.129973 1:CAS:528:DC%2BD1MXpslektL4%3D
4. SE Maynard JY Min J Merchan KH Lim J Li S Mondal TA Libermann JP Morgan FW Sellke IE Stillman FH Epstein VP Sukhatme SA Karumanchi 2003 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 649 658 12618519 1:CAS:528:DC%2BD3sXhvFentbc%3D (Pubitemid 36278583)
5. CW Park HW Kim JH Lim KD Yoo S Chung SJ Shin HW Chung SJ Lee CB Chae YS Kim YS Chang 2009 Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice Diabetes 58 2666 2676 19675133 10.2337/db09-0136 1:CAS:528:DC%2BD1MXhsVCht7%2FK
6. F Xie SE Turvey MA Williams G Mor P von Dadelszen 2010 Toll-like receptor signaling and pre-eclampsia Am J Reprod Immunol 63 7 16 20059464 10.1111/j.1600-0897.2009.00745.x 1:CAS:528:DC%2BC3cXht1antrg%3D
7. G Srikrishna HH Freeze 2009 Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer Neoplasia 11 615 628 19568407 1:CAS:528:DC%2BD1MXnsFSrur8%3D
8. F Xie Y Hu SE Turvey LA Magee RM Brunham KC Choi M Krajden PC Leung DM Money DM Patrick E Thomas P von Dadelszen 2010 Toll-like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre-eclampsia BJOG 117 99 108 20002372 10.1111/j.1471-0528.2009.02428.x 1:CAS:528:DC%2BC3cXht1agtrc%3D
9. H Nishizawa K Pryor-Koishi T Kato H Kowa H Kurahashi Y Udagawa 2007 Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia Placenta 28 487 497 16860862 10.1016/j.placenta.2006.05.010 1:CAS:528:DC%2BD2sXksV2mtr8%3D (Pubitemid 46593762)
10. C Royle S Lim B Xu J Tooher R Ogle A Hennessy 2009 Effect of hypoxia and exogenous IL-10 on the pro-inflammatory cytokine TNF-alpha and the anti-angiogenic molecule soluble Flt-1 in placental villous explants Cytokine 47 56 60 19501525 10.1016/j.cyto.2009.04.006 1:CAS:528:DC%2BD1MXnvVaksLc%3D
11. L Lemmens V Claes M Uzzell 2008 Managing patients with metastatic colorectal cancer on bevacizumab Br J Nurs 17 944 949 18983014
12. A Rajakumar HM Michael PA Rajakumar E Shibata CA Hubel SA Karumanchi R Thadhani M Wolf G Harger N Markovic 2005 Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women Placenta 26 563 573 15993706 10.1016/j.placenta.2004.09.001 1:CAS:528:DC%2BD2MXlvFKls70%3D (Pubitemid 40916309)
13. Molvarec A, Ito M, Shima T, Yoneda S, Toldi G, Stenczer B, Vásárhelyi B, Rigó J Jr, Saito S. Decreased proportion of peripheral blood vascular endothelial growth factor-expressing T and natural killer cells in preeclampsia. Am J Obstet Gynecol. 2010;203:567.e1-8.
14. JM Foidart JP Schaaps F Chantraine C Munaut S Lorquet 2009 Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer J Reprod Immunol 82 106 111 19853925 10.1016/j.jri.2009.09.001 1:CAS:528:DC%2BD1MXhtlylsrrI
15. R Gruemmer K Motejlek D Berghaus HA Weich J Neulen 2005 Regulation of soluble vascular endothelial growth factor receptor (sFlt-1/sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cells Reprod Biol Endocrinol 3 57 16248895 10.1186/1477-7827-3-57 (Pubitemid 41631196)
16. GS Di Marco S Reuter U Hillebrand S Amler M König E Larger H Oberleithner E Brand H Pavenstädt M Brand 2009 The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD J Am Soc Nephrol 20 10 2235 2245 19608702 10.1681/ASN.2009010061 1:CAS:528:DC%2BD1MXhtlSrsbfJ
17. B Kaminska A Wesolowska M Danilkiewicz 2005 TGF beta signalling and its role in tumour pathogenesis Acta Biochim Pol 52 329 337 15990918 1:CAS:528:DC%2BD2MXhtFWisbnE (Pubitemid 41133768)
18. A Ahmed MJ Cudmore 2009 Can the biology of VEGF and haem oxygenases help solve pre-eclampsia? Biochem Soc Trans 37 1237 1242 19909254 10.1042/BST0371237 1:CAS:528:DC%2BD1MXhsVersrzM
19. L Anton KB Brosnihan 2008 Systemic and uteroplacental renin-angiotensin system in normal and pre-eclamptic pregnancies Ther Adv Cardiovasc Dis 2 349 362 19124433 10.1177/1753944708094529
20. G Wallukat V Homuth T Fischer C Lindschau B Horstkamp A Jüpner E Baur E Nissen K Vetter D Neichel JW Dudenhausen H Haller FC Luft 1999 Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor J Clin Invest 103 945 952 10194466 10.1172/JCI4106 1:CAS:528: DyaK1MXitlegs7w%3D (Pubitemid 29169601)
21. CC Zhou S Ahmad T Mi S Abbasi L Xia MC Day SM Ramin A Ahmed RE Kellems Y Xia 2008 Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling Hypertension 51 1010 1019 18259044 10.1161/HYPERTENSIONAHA.107.097790 1:CAS:528:DC%2BD1cXjt1ekt7s%3D (Pubitemid 351398948)
22. RA Irani Y Xia 2008 The functional role of the renin-angiotensin system in pregnancy and preeclampsia Placenta 29 763 771 18687466 10.1016/j.placenta. 2008.06.011 1:CAS:528:DC%2BD1cXhtVOhsrvK
23. AI Papaioannou K Kostikas P Kollia KI Gourgoulianis 2006 Clinical implications for vascular endothelial growth factor in the lung: friend or foe? Respir Res 7 128 17044926 10.1186/1465-9921-7-128 (Pubitemid 44687885)
24. TD Henry BH Annex GR McKendall MA Azrin JJ Lopez FJ Giordano PK Shah JT Willerson RL Benza DS Berman CM Gibson A Bajamonde AC Rundle J Fine ER McCluskey VIVA Investigators 2003 The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis Circulation 107 1359 1365 12642354 10.1161/01.CIR.0000061911.47710.8A 1:CAS:528:DC%2BD3sXhslGjsbo%3D (Pubitemid 36350732)
25. I Zachary G Gliki 2001 Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family Cardiovasc Res 49 568 581 11166270 10.1016/S0008-6363(00)00268-6 1:CAS:528: DC%2BD3MXptlWrtQ%3D%3D (Pubitemid 32146420)
26. T Nakagawa M Segal B Croker RJ Johnson 2007 A breakthrough in diabetic nephropathy: the role of endothelial dysfunction Nephrol Dial Transplant 22 2775 2777 17595179 10.1093/ndt/gfm380 1:CAS:528:DC%2BD2sXhtFWhtbnI (Pubitemid 350093450)
27. IP Eide CV Isaksen KA Salvesen M Langaas SA Schønberg R Austgulen 2008 Decidual expression and maternal serum levels of heme oxygenase 1 are increased in pre-eclampsia Acta Obstet Gynecol Scand 87 272 279 18307065 10.1080/00016340701763015 1:CAS:528:DC%2BD1cXosVGjtb0%3D (Pubitemid 351317474)
28. S Saito A Shiozaki A Nakashima M Sakai Y Sasaki 2007 The role of the immune system in preeclampsia Mol Aspects Med 28 192 209 17433431 10.1016/j.mam.2007.02.006 1:CAS:528:DC%2BD2sXmtVGhu7c%3D (Pubitemid 46843191)
29. B Santner-Nanan MJ Peek R Khanam L Richarts E Zhu B Fazekas de St Groth R Nanan 2009 Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia J Immunol 183 7023 7030 19915051 10.4049/jimmunol.0901154 1:CAS:528:DC%2BD1MXhsVehsb%2FO
30. S Saito 2010 Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia Immunol Cell Biol 88 615 617 20498674 10.1038/icb.2010.68 1:CAS:528:DC%2BC3cXhtVWqu7%2FN
31. N Toda K Ayajiki 2010 Vascular actions of nitric oxide as affected by exposure to alcohol Alcohol Alcohol 45 347 355 20522422 1:CAS:528: DC%2BC3cXotVWitbY%3D
32. S Ueda S Yamagishi S Okuda 2010 New pathways to renal damage: role of ADMA in retarding renal disease progression J Nephrol 23 377 386 20349427
33. M Anderssohn E Schwedhelm N Lüneburg RS Vasan RH Böger 2010 Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus Diab Vasc Dis Res 7 105 118 20382774 10.1177/1479164110366053
34. G,dimethyl-l-arginine and their reversibility by vasodilators in conscious rats Br J Pharmacol 110 1457 1464 8306087 1:CAS:528:DyaK2cXksFGruw%3D%3D (Pubitemid 23360978)
35. PD Speer RW Powers MP Frank G Harger N Markovic JM Roberts 2008 Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants Am J Obstet Gynecol 198 112.e1 112.e7 10.1016/j.ajog.2007.05.052 (Pubitemid 350309261)
36. S Grill C Rusterholz R Zanetti-Dällenbach S Tercanli W Holzgreve S Hahn O Lapaire 2009 Potential markers of preeclampsia-a review Reprod Biol Endocrinol 7 70 19602262 10.1186/1477-7827-7-70
37. NG Than R Romero R Hillermann V Cozzi G Nie B Huppertz 2008 Prediction of preeclampsia-a workshop report Placenta 29 S83 S85 18061661 10.1016/j.placenta.2007.10.008 (Pubitemid 351391770)
38. H Laivuori 2007 Genetic aspects of preeclampsia Front Biosci 12 2372 2382 17127247 10.2741/2239 1:CAS:528:DC%2BD28Xht1OnsbvM
39. BH Sugathadasa KH Tennekoon EH Karunanayake JM Kumarasiri AP Wijesundere 2010 Association of -2548 G/A polymorphism in the leptin gene with preeclampsia/pregnancy-induced hypertension Hypertens Pregnancy 29 4 366 374 20462372 10.3109/10641950903214617 1:CAS:528:DC%2BC3cXht1SntrbL
40. S Goebel M Huang WC Davis M Jennings TJ Siahaan JS Alexander CG Kevil 2006 VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol 290 4 G648 G654 16293653 10.1152/ajpgi.00466.2005 1:CAS:528:DC%2BD28Xks1Slsbs%3D
41. TE Walshe VS Dole AS Maharaj IS Patten DD Wagner PA D'Amore 2009 Inhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rolling Arterioscler Thromb Vasc Biol 29 1185 1192 19461051 10.1161/ATVBAHA.109.186742 1:CAS:528:DC%2BD1MXot1elsbg%3D
42. M Centlow K Junus H Nyström K May I Larsson MG Olsson B Akerström R Sager H Schneider SR Hansson 2009 Perfusion of the human placenta with red blood cells and xanthine oxidase mimics preeclampsia in vitro Z Geburtshilfe Neonatol 213 89 95 19536708 10.1055/s-0029-1224196 1:STN:280:DC%2BD1MvivVSqtw%3D%3D
43. DA Enquobahrie M Meller K Rice BM Psaty DS Siscovick MA Williams 2008 Differential placental gene expression in preeclampsia Am J Obstet Gynecol 199 566.e1 566.e11 10.1016/j.ajog.2008.04.020
44. CW Redman IL Sargent 2003 Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review Placenta 24 S21 S27 12842410 10.1053/plac.2002.0930 (Pubitemid 37184731)
45. L Poston 2006 Endothelial dysfunction in pre-eclampsia Pharmacol Rep 58 69 74 17332674
46. S Sharma WE Norris S Kalkunte 2010 Beyond the threshold: an etiological bridge between hypoxia and immunity in preeclampsia J Reprod Immunol 85 112 116 20236707 10.1016/j.jri.2010.01.002 1:CAS:528:DC%2BC3cXlt1ertL8%3D
47. L Lin S Park EG Lakatta 2009 RAGE signaling in inflammation and arterial aging Front Biosci 14 1403 1413 19273137 10.2741/3315 1:CAS:528: DC%2BD1MXltFejurc%3D
48. JK Riley DM Nelson 2010 Toll-like receptors in pregnancy disorders and placental dysfunction Clin Rev Allergy Immunol 39 185 193 19866377 10.1007/s12016-009-8178-2 1:CAS:528:DC%2BC3cXhtlyntrfO
49. JH Tinsley VL Chiasson A Mahajan KJ Young BM Mitchell 2009 Toll-like receptor 3 activation during pregnancy elicits preeclampsia-like symptoms in rats Am J Hypertens 22 1314 1319 19779466 10.1038/ajh.2009.185 1:CAS:528:DC%2BD1MXhsVentrnM
50. E Nakada KR Walley T Nakada Y Hu P von Dadelszen JH Boyd 2009 Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells Placenta 30 774 779 19631980 10.1016/j.placenta.2009.07.001 1:CAS:528: DC%2BD1MXhtV2qs7nK
51. J Mezquita B Mezquita M Pau C Mezquita 2003 Down-regulation of Flt-1 gene expression by the proteasome inhibitor MG262 J Cell Biochem 89 1138 1147 12898512 10.1002/jcb.10587 1:CAS:528:DC%2BD3sXmtlyrur8%3D (Pubitemid 36959381)
52. MC Lee SC Wei JJ Tsai-Wu CH Wu PN Tsao 2008 Novel PKC signaling is required for LPS-induced soluble Flt-1 expression in macrophages J Leukoc Biol 84 835 841 18511573 10.1189/jlb.1007691 1:CAS:528:DC%2BD1cXhtV2itbbI
53. BB van Rijn A Franx EA Steegers CJ de Groot RM Bertina G Pasterkamp HA Voorbij HW Bruinse M Roest 2008 Maternal TLR4 and NOD2 gene variants, pro-inflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome PLoS One 3 e1865 18382655 10.1371/journal.pone.0001865 (Pubitemid 351943835)
54. R Fraser JJ Walker UV Ekbote KL Martin P McShane NM Orsi 2008 Interleukin-4-590 (C>T), toll-like receptor-2 +2258 (G>A) and matrix metalloproteinase-9-1562 (C>T) polymorphisms in pre-eclampsia BJOG 115 1052 1056 18651887 10.1111/j.1471-0528.2008.01771.x 1:CAS:528:DC%2BD1cXptVWhs7w%3D
55. SF Yan R Ramasamy AM Schmidt 2009 The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease Expert Rev Mol Med 11 e9 19278572 10.1017/S146239940900101X
56. SF Yan R Ramasamy AM Schmidt 2009 Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response J Mol Med 87 235 247 19189073 10.1007/s00109-009-0439-2 1:CAS:528:DC%2BD1MXitVOrtLo%3D
57. C Chekir M Nakatsuka S Noguchi H Konishi Y Kamada A Sasaki L Hao Y Hiramatsu 2006 Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress Placenta 27 225 233 16338468 10.1016/j.placenta.2005.02.016 1:CAS:528: DC%2BD2MXhtlags7%2FL (Pubitemid 41763465)
58. CL Cooke JC Brockelsby PN Baker ST Davidge 2003 The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia Hypertens Pregnancy 22 173 184 12909002 10.1081/PRG-120021068 1:CAS:528: DC%2BD3sXmvFWmsrY%3D (Pubitemid 37521369)
59. S Sankaralingam H Xu Y Jiang T Sawamura ST Davidge 2009 Evidence for increased methylglyoxal in the vasculature of women with preeclampsia: role in upregulation of LOX-1 and arginase Hypertension 54 897 904 19687346 10.1161/HYPERTENSIONAHA.109.135228 1:CAS:528:DC%2BD1MXhtFSns7vK
60. S Sankaralingam Y Xu T Sawamura ST Davidge 2009 Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite Hypertension 53 270 277 19104003 10.1161/HYPERTENSIONAHA.108.122630 1:CAS:528: DC%2BD1MXksl2itQ%3D%3D
61. U Jeschke D Mayr B Schiessl I Mylonas S Schulze C Kuhn K Friese H Walzel 2007 Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas Placenta 28 1165 1173 17664004 10.1016/j.placenta.2007.06.006 1:CAS:528:DC%2BD2sXhtF2qtrnK (Pubitemid 47570909)
62. R Hu H Jin S Zhou P Yang X Li 2007 Proteomic analysis of hypoxia-induced responses in the syncytialization of human placental cell line BeWo Placenta 28 399 407 17098281 10.1016/j.placenta.2006.07.005 1:CAS:528:DC%2BD2sXksV2msb4%3D (Pubitemid 46593774)
63. A Krześlak A Lipińska 2004 Galectin-3 as a multifunctional protein Cell Mol Biol Lett 9 305 328 15213811 (Pubitemid 38902225)
64. Y Iwashima M Eto A Hata K Kaku S Horiuchi F Ushikubi H Sano 2000 Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages Biochem Biophys Res Commun 277 368 380 11032732 10.1006/bbrc.2000.3685 1:CAS:528:DC%2BD3cXntlGitrw%3D
65. C Wadsack A Hammer S Levak-Frank G Desoye KF Kozarsky B Hirschmugl W Sattler E Malle 2003 Selective cholesteryl ester uptake from high density lipoprotein by human first trimester and term villous trophoblast cells Placenta 24 131 143 12566239 10.1053/plac.2002.0912 1:CAS:528:DC%2BD3sXptlOmtA%3D%3D (Pubitemid 37184708)
66. AM Schmidt M Vianna M Gerlach J Brett J Ryan J Kao C Esposito H Hegarty W Hurley M Clauss F Wangll Y-CE Panll TC Tsang D Stern 1992 Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface J Biol Chem 267 14987 14997 1321822 1:CAS:528:DyaK38Xls1Kisbk%3D
67. RD Leslie RM Cohen 2009 Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications J Diabetes Sci Technol 3 635 643 20144305
68. JD Méndez J Xie M Aguilar-Hernández V Méndez- Valenzuela 2010 Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases Mol Cell Biochem 344 185 193 20680411 10.1007/s11010-010-0541-3
69. H Tsukahara N Ohta S Sato M Hiraoka K Shukunami M Uchiyama H Kawakami K Sekine M Mayumi 2004 Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood Free Radic Res 38 691 695 15453634 10.1080/1071576042000220256 1:CAS:528:DC%2BD2cXltFCksLg%3D (Pubitemid 38812087)
70. S Zhang J Zhong P Yang F Gong CY Wang 2009 HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes Int J Clin Exp Pathol 3 24 38 19918326
71. MT Lotze KJ Tracey 2005 High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Nat Rev Immunol 5 331 342 15803152 10.1038/nri1594 1:CAS:528:DC%2BD2MXivVarsr8%3D (Pubitemid 40516158)
72. U Holmlund H Wähämaa N Bachmayer K Bremme E Sverremark-Ekström K Palmblad 2007 The novel inflammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta Immunology 122 430 437 17617154 10.1111/j.1365-2567.2007.02662.x 1:CAS:528:DC%2BD2sXht12jtrbL (Pubitemid 47556480)
73. E Tskitishvili N Sharentuya K Temma-Asano K Mimura Y Kinugasa-Taniguchi T Kanagawa H Fukuda T Kimura T Tomimatsu K Shimoya 2010 Oxidative stress-induced S100B protein from placenta and amnion affects soluble Endoglin release from endothelial cells Mol Hum Reprod 16 188 199 19939849 10.1093/molehr/gap104 1:CAS:528:DC%2BC3cXhslKru7o%3D
74. I Anan S Kiuru-Enari K Obayashi PJ Ranløv Y Ando 2010 Investigation of AGE, their receptor and NF-kappaB activation and apoptosis in patients with ATTR and Gelsolin amyloidosis Histol Histopathol 25 691 699 20376775
75. R Goyal SM Yellon LD Longo E Mata-Greenwood 2010 Placental gene expression in a rat 'model' of placental insufficiency Placenta 31 568 575 20621762 10.1016/j.placenta.2010.05.004 1:CAS:528:DC%2BC3cXosVWmur0%3D
76. F Herse R Dechend NK Harsem G Wallukat J Janke F Qadri L Hering DN Muller FC Luft AC Staff 2007 Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia Hypertension 49 604 611 17261642 10.1161/01.HYP.0000257797.49289.71 1:CAS:528:DC%2BD2sXhslCmsL4%3D
77. GS Lee YS Joe SJ Kim JC Shin 2010 Cytokine-related genes and oxidation-related genes detected in preeclamptic placentas Arch Gynecol Obstet 282 363 369 19787364 10.1007/s00404-009-1222-x 1:CAS:528:DC%2BC3cXhtFWqu7%2FK
78. V Sitras RH Paulssen H Grønaas J Leirvik TA Hanssen A Vårtun G Acharya 2009 Differential placental gene expression in severe preeclampsia Placenta 30 424 433 19249095 10.1016/j.placenta.2009.01.012 1:CAS:528: DC%2BD1MXltFelsrk%3D
79. A Farina D Morano D Arcelli P De Sanctis A Sekizawa Y Purwosunu C Zucchini G Simonazzi T Okai N Rizzo 2009 Gene expression in chorionic villous samples at 11 weeks of gestation in women who develop preeclampsia later in pregnancy: implications for screening Prenat Diagn 29 1038 1044 19731222 10.1002/pd.2344 1:CAS:528:DC%2BD1MXhsFGmsb7K
80. A Farina A Sekizawa Y Purwosunu N Rizzo I Banzola M Concu D Morano F Giommi M Bevini M Mabrook P Carinci T Okai 2006 Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls Prenat Diagn 26 1115 1120 16952198 10.1002/pd.1562 1:CAS:528:DC%2BD2sXitlerur0%3D (Pubitemid 44935273)
81. B Cox M Kotlyar AI Evangelou V Ignatchenko A Ignatchenko K Whiteley I Jurisica SL Adamson J Rossant T Kislinger 2009 Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology Mol Syst Biol 5 279 19536202 10.1038/msb.2009.37
82. JY Han YS Kim GJ Cho GS Roh HJ Kim WJ Choi WY Paik GJ Rho SS Kang WS Choi 2006 Altered gene expression of caspase-10, death receptor-3 and IGFBP-3 in preeclamptic placentas Mol Cells 22 168 174 17085968 1:CAS:528: DC%2BD28Xht1Cnur7E (Pubitemid 46357819)
83. S Gack A Marmé F Marmé G Wrobel B Vonderstrass G Bastert P Lichter P Angel M Schorpp-Kistner 2005 Preeclampsia: increased expression of soluble ADAM 12 J Mol Med 83 887 896 16247621 10.1007/s00109-005-0714-9 1:CAS:528:DC%2BD2MXht1SksbjL (Pubitemid 41598689)
84. IA Lian JH Toft GD Olsen M Langaas L Bjørge IP Eide PE Børdahl R Austgulen 2010 Matrix metalloproteinase 1 in pre-eclampsia and fetal growth restriction: reduced gene expression in decidual tissue and protein expression in extravillous trophoblasts Placenta 31 615 620 20452670 10.1016/j.placenta.2010.04.003 1:CAS:528:DC%2BC3cXosVWmurY%3D
85. CJ Sun L Zhang WY Zhang 2009 Gene expression profiling of maternal blood in early onset severe preeclampsia: identification of novel biomarkers J Perinat Med 37 609 616 19681734 10.1515/JPM.2009.103 1:CAS:528:DC%2BC3cXitlGntQ%3D%3D
86. C Vascotto AM Salzano C D'Ambrosio A Fruscalzo D Marchesoni C di Loreto A Scaloni G Tell F Quadrifoglio 2007 Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia J Proteome Res 6 160 170 17203960 10.1021/pr060315z 1:CAS:528:DC%2BD28XhtF2itL%2FN (Pubitemid 46173668)